{"denoms":[{"counts":[{"groupId":"OG000","value":"0"}],"units":"Participants"}],"description":"The effect of simvastatin and zolendronic acid on M-Protein and FLC ratio will be measured 4 weeks after treatment begins, then every 4 weeks until progression of disease.","groups":[{"description":"Simvastatin and zoledronic acid:\n\n1. Simvastatin 80 mg PO daily starting two days before starting chemotherapy and stopping two days after chemotherapy.\n2. Zoledronic acid 4 mg IV over 15 minutes on day 1 and then monthly.","id":"OG000","title":"Simvastatin and Zolendronic Acid"}],"populationDescription":"NA = Not available, Study was terminated and PI has left the institution. Sincere efforts were made to gather and report the data, however, no data is available for the study","reportingStatus":"POSTED","timeFrame":"4 weeks after treatment begins","title":"Change in Paraprotein Level and Free Light Chain (FLC) Ratio From Baseline Measurement","type":"PRIMARY"}